Issue 2/2019
Content (11 Articles)
Rapid increase in endometrial cancer incidence and ethnic differences in New Zealand
Oliver W. Scott, Sandar Tin Tin, Susan M. Bigby, J. Mark Elwood
Trends in lobular carcinoma in situ management: endocrine therapy use in California and New Jersey
Schelomo Marmor, Bonnie Jerome-D’Emilia, James W. Begun, Jane Yuet Ching Hui, Ariella M. Altman, Scott Kizy, Todd M. Tuttle
Trends in mammography, hormone replacement therapy, and breast cancer incidence and mortality in Canadian women
D. Zakaria, A. Shaw
Predictors of breast cancer mortality among white and black women in large United States cities: an ecologic study
Bijou R. Hunt, Abigail Silva, Derrick Lock, Marc Hurlbert
Non-alcoholic fatty liver disease and colorectal cancer survival
Kana Wu, Mike Z. Zhai, Erin K. Weltzien, Elizabeth M. Cespedes Feliciano, Jeffrey A. Meyerhardt, Edward Giovannucci, Bette J. Caan
Identifying optimal approaches to scale up colorectal cancer screening: an overview of the centers for disease control and prevention (CDC)’s learning laboratory
Florence K. L. Tangka, Sujha Subramanian, Sonja Hoover, Christen Lara, Casey Eastman, Becky Glaze, Mary Ellen Conn, Amy DeGroff, Faye L. Wong, Lisa C. Richardson
The association between longer relative leukocyte telomere length and risk of glioma is independent of the potentially confounding factors allergy, BMI, and smoking
Ulrika Andersson, Sofie Degerman, Anna M. Dahlin, Carl Wibom, Gunnar Johansson, Melissa L. Bondy, Beatrice S. Melin
The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer
Marilyn L. Kwan, Lawrence H. Kushi, Kim N. Danforth, Janise M. Roh, Isaac J. Ergas, Valerie S. Lee, Kimberly L. Cannavale, Teresa N. Harrison, Richard Contreras, Ronald K. Loo, David S. Aaronson, Charles P. Quesenberry, David Tritchler, Nirupa R. Ghai, Virginia P. Quinn, Christine B. Ambrosone, Yuesheng Zhang, Li Tang
Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study
Rhonda Arthur, Henrik Møller, Hans Garmo, Christel Häggström, Lars Holmberg, Pär Stattin, Håkan Malmström, Mats Lambe, Niklas Hammar, Göran Walldius, David Robinson, Ingmar Jungner, Mieke Van Hemelrijck
Physiologic serum 1,25 dihydroxyvitamin D is inversely associated with prostatic Ki67 staining in a diverse sample of radical prostatectomy patients
Adrian Rosenberg, Oluwarotimi S. Nettey, Pooja Gogana, Ujalla Sheikh, Virgilia Macias, Andre Kajdacsy-Balla, Roohollah Sharifi, Rick A. Kittles, Adam B. Murphy
Correction to: The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer
Eric A. Miller, Paul F. Pinsky, Dudith Pierre-Victor